Pricing Log in Create free account

Century Therapeutics, Inc. (IPSC) vs Turn Therapeutics Inc. (TTRX)

Century Therapeutics, Inc. and Turn Therapeutics Inc. are both Biotechnology companies. Century Therapeutics, Inc. and Turn Therapeutics Inc. are of similar size ($273.4M and $273.0M). Across the 10 metrics below, Century Therapeutics, Inc. leads on 6 and Turn Therapeutics Inc. on 4.

Valuation

Metric IPSC TTRX Biotechnology median
P/E n/m n/m 10.60
P/S 3.03 n/m 9.40
P/B 1.50 403.30 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA n/m n/m 0.66
EV/Sales 1.99 n/m 9.02
Earnings yield (55.03%) (3.12%) (32.88%)
Free cash flow yield (25.31%) (1.61%) (23.13%)

Profitability

Metric IPSC TTRX Biotechnology median
Gross margin 100.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (49.65%) (3,315.33%) (51.96%)
Return on assets (38.41%) (99.59%) (46.06%)
Return on invested capital (64.92%) 0.00% 0.00%

Growth

Metric IPSC TTRX Biotechnology median
Revenue growth (TTM) 8,286.72% — 6.76%
EPS growth (last fiscal year) 91.30% (80.72%) 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric IPSC TTRX Biotechnology median
Debt to equity 0.00 8.83 0.00
Current ratio 8.28 1.19 4.97
Net debt to EBITDA 17.95 0.96 1.01

Dividend

Metric IPSC TTRX Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric IPSC TTRX Biotechnology median
Market cap 273.43m 272.96m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack